TABLE 1. Characteristics of 229 Participants With Coronary Disease, Including 118 With Exercise-Induced Ischemia and 111 Without Inducible Ischemia.
Variable | Ischemia (n=118) |
No Ischemia (n=111) |
P Value |
---|---|---|---|
Age, y | 71.9±9.2 | 66.9±10.9 | <0.001 |
Male sex, % | 95 | 95 | 0.91 |
White race, % | 67 | 58 | 0.15 |
History, % | |||
Hypertension | 71 | 70 | 0.84 |
Myocardial infarction | 65 | 51 | 0.03 |
Congestive heart failure | 26 | 7 | <0.001 |
Stroke | 13 | 11 | 0.66 |
Diabetes | 32 | 21 | 0.07 |
Coronary artery bypass grafting | 47 | 47 | 0.92 |
Angioplasty | 32 | 49 | 0.009 |
Current smoking, % | 18 | 19 | 0.80 |
Body mass index, kg/m2 | 27.8±5.0 | 28.0±4.4 | 0.77 |
Exercise capacity, METs | 5.9±2.5 | 9.0±2.6 | <0.001 |
Left ventricular ejection fraction | 0.61±0.11 | 0.64±0.09 | 0.006 |
Current angina, % | 39 | 32 | 0.24 |
Medication, % | |||
β-Blocker | 62 | 60 | 0.82 |
Statin | 68 | 74 | 0.31 |
ACE inhibitor | 55 | 39 | 0.01 |
Aspirin | 86 | 79 | 0.21 |
Estrogen (in women) | 17 | 50 | 0.55 |
Labs | |||
LDL cholesterol | 105.1±34.3 | 107.1±32.9 | 0.67 |
HDL cholesterol | 45.7±16.7 | 47.5±12.4 | 0.36 |
Total/HDL cholesterol | 4.2±1.4 | 4.0±1.2 | 0.24 |
Creatinine clearance | 70.9±23.3 | 86.0±28.2 | <0.001 |
Values are expressed as mean±SD or percent. ACE indicate angiotensin-converting enzyme.